 |
|
Precision medicine for pediatric inflammatory bowel disease: a perspective
Yon Ho Choe
Precis Future Med. 2020;4(2):43-52. Published online 2020 May 27 DOI: https://doi.org/10.23838/pfm.2020.00058
|
|
Citations to this article as recorded by
 Discontinuation of Azathioprine could be considered in pediatric patients with Crohn’s disease who have sustained clinical and deep remission
Tae Jong Jeong, Eun Sil Kim, Yiyoung Kwon, Seonwoo Kim, Sang Won Seo, Yon Ho Choe, Mi Jin Kim
Scientific Reports.2022;[Epub] CrossRef Pediatric-onset Inflammatory Bowel Disease: What Are Different from Adult in the Treatment?
Soyoon Choi, Won Moon
The Korean Journal of Gastroenterology.2021; 77(5): 220. CrossRef
|